Previous studies strongly associated cancers involving TP53 mutation, MYC amplification and c-JUN oncogene overexpression with an overexpression of GLS1, which favours glutaminolysis.[80], [81], [82], [83] Such cancers behave like mouse Myc liver tumours, being both glycolytic and glutaminolytic. The gene discussed is MYC; the disease is cancer.